{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T10:55:23Z","timestamp":1774868123270,"version":"3.50.1"},"reference-count":72,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T00:00:00Z","timestamp":1440720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0136930","type":"journal-article","created":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T14:35:52Z","timestamp":1440772552000},"page":"e0136930","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Generation of SNCA Cell Models Using Zinc Finger Nuclease (ZFN) Technology for Efficient High-Throughput Drug Screening"],"prefix":"10.1371","volume":"10","author":[{"given":"Warunee","family":"Dansithong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharan","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel R.","family":"Scoles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan M.","family":"Pulst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duong P.","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,8,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/mds.25421","article-title":"Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson&apos;s disease","volume":"28","author":"S Appel-Cresswell","year":"2013","journal-title":"Mov Disord"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"Alpha-synuclein locus duplication as a cause of familial Parkinson&apos;s disease","volume":"364","author":"MC Chartier-Harlin","year":"2004","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.arr.2014.04.002","article-title":"Genetic variants and animal models in SNCA and Parkinson disease","volume":"15","author":"H Deng","year":"2014","journal-title":"Ageing Res Rev"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson&apos;s disease","volume":"276","author":"MH Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.parkreldis.2013.01.020","article-title":"Monogenic Parkinson&apos;s disease and parkinsonism: clinical phenotypes and frequencies of known mutations","volume":"19","author":"A Puschmann","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"alpha-Synuclein locus triplication causes Parkinson&apos;s disease","volume":"302","author":"AB Singleton","year":"2003","journal-title":"Science"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson&apos;s disease","volume":"18","author":"R Kruger","year":"1998","journal-title":"Nat Genet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00401-013-1096-7","article-title":"alpha-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson&apos;s disease and multiple system atrophy?","volume":"125","author":"AP Kiely","year":"2013","journal-title":"Acta Neuropathol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0140-6736(04)17104-3","article-title":"Causal relation between alpha-synuclein gene duplication and familial Parkinson&apos;s disease","volume":"364","author":"P Ibanez","year":"2004","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.22400","article-title":"Acid beta-glucosidase mutants linked to gaucher disease, parkinson disease, and lewy body dementia alter alpha-synuclein processing","volume":"69","author":"V Cullen","year":"2011","journal-title":"Ann Neurol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.12.051","article-title":"Telmisartan Reduces Progressive Oxidative Stress and Phosphorylated alpha-Synuclein Accumulation in Stroke-resistant Spontaneously Hypertensive Rats after Transient Middle Cerebral Artery Occlusion","volume":"23","author":"K Sato","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"9879","DOI":"10.1073\/pnas.1004676107","article-title":"Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice","volume":"107","author":"Y Tong","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"10813","DOI":"10.1073\/pnas.152339799","article-title":"alpha-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson&apos;s disease","volume":"99","author":"C Lo Bianco","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"17510","DOI":"10.1073\/pnas.0405313101","article-title":"Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson&apos;s disease","volume":"101","author":"C Lo Bianco","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","article-title":"Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders","volume":"287","author":"E Masliah","year":"2000","journal-title":"Science"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.neuroscience.2006.06.052","article-title":"Dynamic modeling of alpha-synuclein aggregation for the sporadic and genetic forms of Parkinson&apos;s disease","volume":"142","author":"A Raichur","year":"2006","journal-title":"Neuroscience"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1126\/science.1067389","article-title":"Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson&apos;s disease","volume":"295","author":"PK Auluck","year":"2002","journal-title":"Science"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/mds.21007","article-title":"Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients","volume":"21","author":"O Chiba-Falek","year":"2006","journal-title":"Mov Disord"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1093\/nar\/gkn084","article-title":"Elevated alpha-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson&apos;s disease","volume":"36","author":"J Grundemann","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2174\/138920309789351912","article-title":"Enhanced alpha-synuclein expression in human neurodegenerative diseases: pathogenetic and therapeutic implications","volume":"10","author":"AL McCormack","year":"2009","journal-title":"Curr Protein Pept Sci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/jcp.20719","article-title":"Parkin potentiates ATP-induced currents due to activation of P2X receptors in PC12 cells","volume":"209","author":"A Sato","year":"2006","journal-title":"J Cell Physiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1750-1326-5-47","article-title":"Parkinson-related parkin reduces alpha-Synuclein phosphorylation in a gene transfer model","volume":"5","author":"PJ Khandelwal","year":"2010","journal-title":"Mol Neurodegener"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e12122","DOI":"10.1371\/journal.pone.0012122","article-title":"Alpha-synuclein suppression by targeted small interfering RNA in the primate substantia nigra","volume":"5","author":"AL McCormack","year":"2010","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1038\/mtna.2015.14","article-title":"Normalization of Overexpressed alpha-Synuclein Causing Parkinson&apos;s Disease By a Moderate Gene Silencing With RNA Interference","volume":"4","author":"M Takahashi","year":"2015","journal-title":"Mol Ther Nucleic Acids"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0896-6273(00)80886-7","article-title":"Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system","volume":"25","author":"A Abeliovich","year":"2000","journal-title":"Neuron"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"8797","DOI":"10.1523\/JNEUROSCI.22-20-08797.2002","article-title":"Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein","volume":"22","author":"DE Cabin","year":"2002","journal-title":"J Neurosci"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1093\/hmg\/10.26.3101","article-title":"Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system","volume":"10","author":"O Chiba-Falek","year":"2001","journal-title":"Hum Mol Genet"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1101\/gr.165801","article-title":"Human and mouse alpha-synuclein genes: comparative genomic sequence analysis and identification of a novel gene regulatory element","volume":"11","author":"JW Touchman","year":"2001","journal-title":"Genome Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s00439-003-1002-9","article-title":"Functional analysis of intra-allelic variation at NACP-Rep1 in the alpha-synuclein gene","volume":"113","author":"O Chiba-Falek","year":"2003","journal-title":"Hum Genet"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/1531-8249(199905)45:5<611::AID-ANA9>3.0.CO;2-X","article-title":"Increased susceptibility to sporadic Parkinson&apos;s disease by a certain combined alpha-synuclein\/apolipoprotein E genotype","volume":"45","author":"R Kruger","year":"1999","journal-title":"Ann Neurol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ana.410400212","article-title":"Genetic studies in Alzheimer&apos;s disease with an NACP\/alpha-synuclein polymorphism","volume":"40","author":"Y Xia","year":"1996","journal-title":"Ann Neurol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1523\/JNEUROSCI.6119-09.2010","article-title":"Methylation regulates alpha-synuclein expression and is decreased in Parkinson&apos;s disease patients&apos; brains","volume":"30","author":"A Jowaed","year":"2010","journal-title":"J Neurosci"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e15522","DOI":"10.1371\/journal.pone.0015522","article-title":"CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson&apos;s disease","volume":"5","author":"L Matsumoto","year":"2010","journal-title":"PLoS One"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1126\/science.1152850","article-title":"Gene regulation in the third dimension","volume":"319","author":"J Dekker","year":"2008","journal-title":"Science"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature11279","article-title":"The long-range interaction landscape of gene promoters","volume":"489","author":"A Sanyal","year":"2012","journal-title":"Nature"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nbt.1562","article-title":"Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases","volume":"27","author":"D Hockemeyer","year":"2009","journal-title":"Nat Biotechnol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"10915","DOI":"10.1073\/pnas.1202768109","article-title":"Zinc-finger nuclease-mediated targeted insertion of reporter genes for quantitative imaging of gene expression in sea urchin embryos","volume":"109","author":"H Ochiai","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cell.2011.06.019","article-title":"Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations","volume":"146","author":"F Soldner","year":"2011","journal-title":"Cell"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1093\/hmg\/dds349","article-title":"ETS1 regulates the expression of ATXN2","volume":"21","author":"DR Scoles","year":"2012","journal-title":"Hum Mol Genet"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.bbrc.2014.05.132","article-title":"Acetylation regulates the stability of glutamate carboxypeptidase II protein in human astrocytes","volume":"450","author":"JY Choi","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"38427","DOI":"10.1074\/jbc.M111.255224","article-title":"Expanded CUG repeats Dysregulate RNA splicing by altering the stoichiometry of the muscleblind 1 complex","volume":"286","author":"S Paul","year":"2011","journal-title":"J Biol Chem"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"e23939","DOI":"10.1371\/journal.pone.0023939","article-title":"Improved immunodetection of endogenous alpha-synuclein","volume":"6","author":"BR Lee","year":"2011","journal-title":"PLoS One"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/978-1-61779-163-5_30","article-title":"UV-laser microdissection and mRNA expression analysis of individual neurons from postmortem Parkinson&apos;s disease brains","volume":"755","author":"J Grundemann","year":"2011","journal-title":"Methods Mol Biol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00702-004-0263-3","article-title":"The role of alpha-synuclein gene multiplications in early-onset Parkinson&apos;s disease and dementia with Lewy bodies","volume":"112","author":"A Hofer","year":"2005","journal-title":"J Neural Transm"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/sj.mp.4001893","article-title":"Valproate protects dopaminergic neurons in midbrain neuron\/glia cultures by stimulating the release of neurotrophic factors from astrocytes","volume":"11","author":"PS Chen","year":"2006","journal-title":"Mol Psychiatry"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.neuroscience.2011.10.031","article-title":"Potential autophagy enhancers attenuate rotenone-induced toxicity in SH-SY5Y","volume":"199","author":"N Xiong","year":"2011","journal-title":"Neuroscience"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1523\/JNEUROSCI.0096-06.2006","article-title":"Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity","volume":"26","author":"Y Leng","year":"2006","journal-title":"J Neurosci"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays","volume":"4","author":"JH Zhang","year":"1999","journal-title":"J Biomol Screen"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1212\/01.WNL.0000127517.33208.F4","article-title":"Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication","volume":"62","author":"DW Miller","year":"2004","journal-title":"Neurology"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"e17698","DOI":"10.1371\/journal.pone.0017698","article-title":"Progressive neurodegeneration or endogenous compensation in an animal model of Parkinson&apos;s disease produced by decreasing doses of alpha-synuclein","volume":"6","author":"JB Koprich","year":"2011","journal-title":"PLoS One"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.brainres.2011.04.036","article-title":"An alpha-synuclein AAV gene silencing vector ameliorates a behavioral deficit in a rat model of Parkinson&apos;s disease, but displays toxicity in dopamine neurons","volume":"1395","author":"CE Khodr","year":"2011","journal-title":"Brain Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.bbrc.2006.01.057","article-title":"Down-regulation of alpha-synuclein expression can rescue dopaminergic cells from cell death in the substantia nigra of Parkinson&apos;s disease rat model","volume":"341","author":"H Hayashita-Kinoh","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.bbamcr.2013.11.018","article-title":"Mechanism of cleavage of alpha-synuclein by the 20S proteasome and modulation of its degradation by the RedOx state of the N-terminal methionines","volume":"1843","author":"B Alvarez-Castelao","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.nbd.2011.01.029","article-title":"Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission","volume":"42","author":"L Alvarez-Erviti","year":"2011","journal-title":"Neurobiol Dis"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"14508","DOI":"10.1523\/JNEUROSCI.1560-11.2011","article-title":"Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of alpha-synuclein","volume":"31","author":"D Ebrahimi-Fakhari","year":"2011","journal-title":"J Neurosci"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4161\/auto.8.2.18938","article-title":"Alpha-synuclein&apos;s degradation in vivo: opening a new (cranial) window on the roles of degradation pathways in Parkinson disease","volume":"8","author":"D Ebrahimi-Fakhari","year":"2012","journal-title":"Autophagy"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"754","DOI":"10.4161\/auto.19371","article-title":"Alpha-synuclein aggregation involves a bafilomycin A 1-sensitive autophagy pathway","volume":"8","author":"J Klucken","year":"2012","journal-title":"Autophagy"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"630","DOI":"10.2174\/18715273113126660195","article-title":"alpha-Synuclein Ubiquitination and Novel Therapeutic Targets for Parkinson&apos;s Disease","volume":"13","author":"R Rott","year":"2014","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref59","article-title":"Identification of a small molecule that selectively activates alpha-synuclein translational expression","author":"NT Ross","journal-title":"Identification of a small molecule that selectively activates alpha-synuclein translational expression"},{"key":"ref60","article-title":"Identification of a small molecule that selectively inhibits alpha-synuclein translational expression","author":"NT Ross","year":"2011","journal-title":"Identification of a small molecule that selectively inhibits alpha-synuclein translational expression"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1038\/emm.2013.45","article-title":"Autophagic failure promotes the exocytosis and intercellular transfer of alpha-synuclein","volume":"45","author":"HJ Lee","year":"2013","journal-title":"Exp Mol Med"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"13621","DOI":"10.1074\/jbc.M109.074617","article-title":"Lysosomal degradation of alpha-synuclein in vivo","volume":"285","author":"SK Mak","year":"2010","journal-title":"J Biol Chem"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"17004","DOI":"10.1073\/pnas.1109356108","article-title":"Ubiquitin ligase Nedd4 promotes alpha-synuclein degradation by the endosomal-lysosomal pathway","volume":"108","author":"GK Tofaris","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"25009","DOI":"10.1074\/jbc.M300227200","article-title":"Alpha-Synuclein is degraded by both autophagy and the proteasome","volume":"278","author":"JL Webb","year":"2003","journal-title":"J Biol Chem"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1126\/science.1101738","article-title":"Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy","volume":"305","author":"AM Cuervo","year":"2004","journal-title":"Science"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies","volume":"146","author":"JR Mazzulli","year":"2011","journal-title":"Cell"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ng.300","article-title":"Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity","volume":"41","author":"AD Gitler","year":"2009","journal-title":"Nat Genet"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/humu.21527","article-title":"Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism","volume":"32","author":"JS Park","year":"2011","journal-title":"Hum Mutat"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1093\/hmg\/dds206","article-title":"Identification of novel ATP13A2 interactors and their role in alpha-synuclein misfolding and toxicity","volume":"21","author":"M Usenovic","year":"2012","journal-title":"Hum Mol Genet"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/ng.337","article-title":"Bridging high-throughput genetic and transcriptional data reveals cellular responses to alpha-synuclein toxicity","volume":"41","author":"E Yeger-Lotem","year":"2009","journal-title":"Nat Genet"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.nbd.2013.12.011","article-title":"Enhanced ubiquitin-dependent degradation by Nedd4 protects against alpha-synuclein accumulation and toxicity in animal models of Parkinson&apos;s disease","volume":"64","author":"SE Davies","year":"2014","journal-title":"Neurobiol Dis"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1242\/dmm.004267","article-title":"Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson&apos;s disease models","volume":"3","author":"LJ Su","year":"2010","journal-title":"Dis Model Mech"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0256366","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T00:00:00Z","timestamp":1628726400000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0136930","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T17:59:39Z","timestamp":1588960779000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0136930"}},"subtitle":[],"editor":[{"given":"Patrick","family":"Lewis","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,8,28]]},"references-count":72,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,8,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0136930","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,28]]}}}